Factors influencing the occurrence of electrolyte disorders in cancer patients

被引:4
作者
Alem, Addis [1 ]
Edae, Chala Kenenisa [1 ]
Wabalo, Endriyas Kelta [1 ]
Tareke, Amare Abera [2 ]
Bedanie, Almaz Ayalew [2 ]
Reta, Wondu [2 ]
Bariso, Moyeta [2 ]
Bekele, Gadisa [3 ]
Zawdie, Belay [1 ]
机构
[1] Jimma Univ, Inst Hlth, Dept Biomed Sci, Biochem Unit, POB 379, Jimma, Ethiopia
[2] Jimma Univ, Inst Hlth, Dept Biomed Sci, Physiol Unit, Jimma, Ethiopia
[3] Jimma Univ, Inst Hlth, Dept Nursing, Jimma, Ethiopia
来源
SAGE OPEN MEDICINE | 2021年 / 9卷
关键词
Cancer; electrolyte disorders; Ethiopia; influencing factors; HYPONATREMIA; COMORBIDITY; SURVIVAL; AGE; IMPACT; WOMEN;
D O I
10.1177/20503121211052861
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of this study was to determine the magnitude of electrolyte disorders and influencing factors among cancer patients in Southwest Ethiopia. Methods: Facility-based cross-sectional study was conducted in Jimma Medical Center (JMC). Eighty-four cancer patients admitted to JMC were recruited for this study. A structured questionnaire and serum electrolyte measurements were used for data collection. Bivariate and multiple logistic regression was employed to determine the association between electrolyte disorders and associated factors among admitted cancer patients. P value <= 0.05 was used as a cut point to declare statistical significance. Result: The overall prevalence of electrolyte disorders was 60.7%. The presence or absence of comorbid diseases, age, body mass index (BMI), nutritional status, and current prescribed medication use were associated with electrolyte disorders. Younger patients had lower odds for electrolyte disorders (odds ratio (OR) = 0.128 (P value = 0.05) and OR = 0.08 (P value = 0.033)) for the first and the second quartile, respectively. Underweight patients had a threefold likelihood to develop electrolyte disorders (OR = 3.13 (P value = 0.043)) than having normal BMI. Compared with those in need of nutritional intervention, patients not in need of nutritional intervention had lower odds for the disorders (OR = 0.109 (P value = 0.006)). Medication had increased the likelihood of electrolyte disorders by 5.5 times than with no medication (P value = 0.023). Those who had comorbid disease had 10 times likely to develop electrolyte disorders than those who did not have comorbid diseases (P value = 0.004). Conclusion: Electrolyte disorders were prevalent in cancer patients. Age, BMI, nutritional condition, comorbid disease, and prescribed drugs were the predictors of electrolyte disorders in cancer patients. Authors recommend routine screening of electrolyte disorders in cancer patients and special emphasis on controlling and managing risk factors.
引用
收藏
页数:7
相关论文
共 32 条
  • [1] Health Related Quality of Life of Cancer Patients in Ethiopia
    Abegaz, Tadesse Melaku
    Ayele, Asnakew Achaw
    Gebresillassie, Begashaw Melaku
    [J]. JOURNAL OF ONCOLOGY, 2018, 2018
  • [2] [Anonymous], The alcohol, smoking and substance involvement screening test (ASSIST): Manual for use in primary care
  • [3] Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
    Arvold, Nils D.
    Taghian, Alphonse G.
    Niemierko, Andrzej
    Raad, Rita F. Abi
    Sreedhara, Meera
    Nguyen, Paul L.
    Bellon, Jennifer R.
    Wong, Julia S.
    Smith, Barbara L.
    Harris, Jay R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (29) : 3885 - 3891
  • [4] Balci AK, 2013, WORLD J EMERG MED, V4, P113, DOI [10.5847/wjem.j.issn.1920-8642.2013.02.005, 10.5847/wjem.j.1920-8642.2013.02.005]
  • [5] Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer
    Bauer, J
    Capra, S
    Ferguson, M
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (08) : 779 - 785
  • [6] Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients
    Berardi, R.
    Caramanti, M.
    Castagnani, M.
    Guglielmi, S.
    Marcucci, F.
    Savini, A.
    Morgese, F.
    Rinaldi, S.
    Ferrini, C.
    Tiberi, M.
    Torniai, M.
    Rovinelli, F.
    Fiordoliva, I.
    Onofri, A.
    Cascinu, S.
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (10) : 3095 - 3101
  • [7] INFLUENCE OF AGE AND COMORBIDITY ON TREATMENT CHOICE AND SURVIVAL IN ELDERLY PATIENTS WITH BREAST-CANCER
    BERGMAN, L
    DEKKER, G
    VANKERKHOFF, EHM
    PETERSE, HL
    VANDONGEN, JA
    VANLEEUWEN, FE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1991, 18 (03) : 189 - 198
  • [8] Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer
    Bilgetekin, Irem
    Erturk, Ismail
    Basal, Fatma Bugdayci
    Karacin, Cengiz
    Karadurmus, Nuri
    Oksuzoglu, Berna
    Demirci, Umut
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 301 - 307
  • [9] DRUG-INDUCED ELECTROLYTE ABNORMALITIES
    BRASS, EP
    THOMPSON, WL
    [J]. DRUGS, 1982, 24 (03) : 207 - 228
  • [10] The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis
    Corona, Giovanni
    Giuliani, Corinna
    Parenti, Gabriele
    Colombo, Giorgio L.
    Sforza, Alessandra
    Maggi, Mario
    Forti, Gianni
    Peri, Alessandro
    [J]. AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08) : 823 - +